Skip to main content
. 2014 Dec 19;3:31. doi: 10.1186/2162-3619-3-31

Figure 4.

Figure 4

Flow cytometric analysis of WSU-WM xenograft tumors. A. Phenotype of tumor cells in control (untreated) and following rituximab therapy, B. CD20 expression in residual tumors removed at days 7 and 9 post completion of RTX therapy compared with day of completion of therapy (day 0) and with tumors of untreated animals (untreated).